News

Thumbnail

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

Siemens Healthineers invests $30M into new radiopharma facility

The new site will have up to eight times the manufacturing capacity of any other radiopharmaceutical facility. 

Thumbnail

A special report is raising new concerns about a hospital’s lackluster response to a radiologist's concerns of abuse happening in the organization's NICU.

Heart cardiologists doctors surgery

Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.

The Boston Scientific BodyGuardian Remote Monitoring System uses AI to help detect and monitor cardiac arrhythmias in ambulatory patients.

Cardiology remains the No. 2 healthcare specialty for AI approvals, trailing only radiology. 

Midwest Radiology

Midwest Radiology Director of Recruiting Laurent Grignon, MD, recently spoke with Radiology Business about the successes, divulging some of his strategies. 

AIRS Medical

Founded in 2018, AIRS provides deep-learning solutions including its flagship SwiftMR, which it says reduces scan times while boosting image quality. 

signature

The largest Medicaid-specialized managed care organization in the U.S. is offering buyout packages to most of its 60,000 or so staff workers.

insurance network out-of-network insurer coverage

The deal is with Golden State Imaging Associates, which serves Southern California, providing 24/7 diagnostic and interventional services to hospitals and other referrers. 

supplements for lunch

Some of today’s most popular products promise better immune, adaptogenic, anti-inflammatory, gut, skin or joint health—or combinations of two or more of the above.  

Phishing Hack Data Breach Password

Tennessee-based Xsolis said the incident occurred in January, and the sensitive data was from its clients. The company provides AI-powered case management software to hospitals and health insurers.

Drugs money scam

As the Medicare drug price negotiation program enters its fourth year next year, regulators are looking to put a set of guidelines in place that make it clear how medications are selected for inclusion and what the deliberation process will look like for biopharma companies.

Around the web

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

The new site will have up to eight times the manufacturing capacity of any other radiopharmaceutical facility. 

A special report is raising new concerns about a hospital’s lackluster response to a radiologist's concerns of abuse happening in the organization's NICU.